United Laboratories International Holdings Ltd

UNJ

Company Profile

  • Business description

    United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.

  • Contact

    No. 6 Fuk Wang Street
    Yuen Long Industrial Estate
    New Territories
    Hong Kong
    HKG

    http://www.tul.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    15,000

Stocks News & Analysis

stocks

Why ASX miners will handily beat banks in the long-term

After a stellar run for banks, investors are wondering whether they can continue their outperformance or if a rotation into miners is imminent. There’s a good case that a switch is coming, and it may last decades, not just years. 
stocks

How to avoid dividend disaster

Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.
video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,785.10101.701.17%
CAC 408,001.97110.291.40%
DAX 4021,866.98281.051.30%
Dow JONES (US)44,857.1816.10-0.04%
FTSE 1008,748.11124.821.45%
HKSE20,891.62294.531.43%
NASDAQ19,710.2217.890.09%
Nikkei 22539,066.53235.050.61%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,070.378.890.15%
S&P/ASX 2008,520.70103.801.23%
SSE Composite Index3,270.6641.171.27%

Market Movers